In addition to being used as frontline therapy, chemotherapy is also used as neoadjuvant therapy to reduce tumor size prior to surgery or in combination with several of the newer biological therapies (e.g., antibodies against CTLA4, PD1, and Her2)45. Here, ERBB2 is linked to neoplasm.